HCRP1 downregulation confers poor prognosis and induces chemoresistance through regulation of EGFR-AKT pathway in human gastric cancer
Virchows Archiv Oct 18, 2017
Xu H, et al. - The biological roles and clinical significance of HCRP1 were comprehensively analyzed in human gastric cancer. The inference drawn was that HCRP1 downregulation possibly presented as an indicator of the poor prognosis in gastric cancer patients. The drug resistance was reduced by HCRP1 through the regulation of EGFR-AKT signaling.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
